Non-proliferative Diabetic Retinopathy Treated With Runcaciguat

Clinical trial NCT04722991 · COMPLETED

Trial details

NCT number: NCT04722991
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Retinopathy

Start date: 2021-03-17
Primary completion: 2024-03-18
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.